FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791689651> ?p ?o ?g. }

• W2791689651 endingPage "1133" @default.
• W2791689651 startingPage "1125" @default.
• W2791689651 abstract "Vitamin D (VD) plays an important role in bone mineralization. The present study investigates the effect of VD supplementation alone on bone turnover markers in younger postmenopausal women. It has been shown that VD supplementation in postmenopausal women with hypovitaminosis D is associated with a reduction in bone turnover markers. The purpose of this study is to evaluate the effect of VD supplementation alone on bone turnover markers in younger postmenopausal women. In this double-blind, placebo-controlled trial, 160 women were randomized into the VD group (supplementation with 1000 IU of vitamin D3/day, orally; n = 80) or placebo group (n = 80). Women aged 50–65 years with amenorrhea ≥ 12 months and normal bone mineral density were included. The intervention lasted 9 months, and the participants were assessed at the beginning and end of treatment. Serum levels of total calcium, parathormone (PTH), alkaline phosphatase (AP), and 24-h urine calcium were determined. Serum C-terminal telopeptide of type I collagen (s-CTX) and procollagen type 1 N-terminal propeptide (P1NP) were measured by immunoassay as markers of bone resorption and formation, respectively. Plasma 25-hydroxyvitamin-D [25(OH)D] concentrations were measured by HPLC. Intention-to-treat analysis was performed using ANOVA, Student’s t test, Tukey’s test, and gamma distribution. Over the period of 9 months, 25(OH)D concentrations increased from 15.0 ± 7.5 to 27.5 ± 10.4 ng/mL (+ 45.4%) in the VD group and decreased from 16.9 ± 6.7 to 13.8 ± 6.0 ng/mL (− 18.5%) in the placebo group (p < 0.001). There was a decrease (− 21.3%) of PTH levels in the VD group with a significant difference between groups at the end of the study (p < 0.001). No significant differences were observed in the other laboratory parameters (total calcium, AP, and calciuria) in either group (p > 0.05). A comparison of bone turnover markers showed a significant reduction in of s-CTX (− 24.2%, p < .0001) and P1NP (− 13.4%, p = 0.003) levels in the VD group. No significant variations in bone turnover markers were observed in the placebo group (s-CTX, − 6.9%, p = 0.092 and P1NP, − 0.6%, p = 0.918). In younger postmenopausal women with VD deficiency, isolated supplementation with 1000 IU of vitamin D3 for 9 months is associated with a reduction in bone turnover markers. However, any between-group differences was not observed in bone turnover markers." @default.
• W2791689651 created "2018-03-29" @default.
• W2791689651 creator A5017540902 @default.
• W2791689651 creator A5056768431 @default.
• W2791689651 creator A5064526709 @default.
• W2791689651 creator A5065771148 @default.
• W2791689651 creator A5081482078 @default.
• W2791689651 creator A5083267991 @default.
• W2791689651 creator A5086297428 @default.
• W2791689651 date "2018-02-15" @default.
• W2791689651 modified "2023-10-02" @default.
• W2791689651 title "Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial" @default.
• W2791689651 cites W13079746 @default.
• W2791689651 cites W1472103314 @default.
• W2791689651 cites W1494185596 @default.
• W2791689651 cites W1916476645 @default.
• W2791689651 cites W1975602447 @default.
• W2791689651 cites W1982871637 @default.
• W2791689651 cites W2000368083 @default.
• W2791689651 cites W2005779589 @default.
• W2791689651 cites W2006291928 @default.
• W2791689651 cites W2009779320 @default.
• W2791689651 cites W2010291853 @default.
• W2791689651 cites W2013187556 @default.
• W2791689651 cites W2023471859 @default.
• W2791689651 cites W2026323279 @default.
• W2791689651 cites W2033047327 @default.
• W2791689651 cites W2049103906 @default.
• W2791689651 cites W2051550558 @default.
• W2791689651 cites W2074347967 @default.
• W2791689651 cites W2074982762 @default.
• W2791689651 cites W2097055008 @default.
• W2791689651 cites W2099665543 @default.
• W2791689651 cites W2116841061 @default.
• W2791689651 cites W2117297406 @default.
• W2791689651 cites W2118540989 @default.
• W2791689651 cites W2120241921 @default.
• W2791689651 cites W2124070987 @default.
• W2791689651 cites W2124139470 @default.
• W2791689651 cites W2138336132 @default.
• W2791689651 cites W2146587019 @default.
• W2791689651 cites W2153059487 @default.
• W2791689651 cites W2160303411 @default.
• W2791689651 cites W2169728499 @default.
• W2791689651 cites W2169970337 @default.
• W2791689651 cites W2171709369 @default.
• W2791689651 cites W2322573421 @default.
• W2791689651 cites W2609966193 @default.
• W2791689651 cites W2774861105 @default.
• W2791689651 cites W326642456 @default.
• W2791689651 cites W4211100531 @default.
• W2791689651 cites W4230870013 @default.
• W2791689651 cites W2426192783 @default.
• W2791689651 doi "https://doi.org/10.1007/s00198-018-4395-y" @default.
• W2791689651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29450585" @default.
• W2791689651 hasPublicationYear "2018" @default.
• W2791689651 type Work @default.
• W2791689651 sameAs 2791689651 @default.
• W2791689651 citedByCount "23" @default.
• W2791689651 countsByYear W27916896512018 @default.
• W2791689651 countsByYear W27916896512019 @default.
• W2791689651 countsByYear W27916896512020 @default.
• W2791689651 countsByYear W27916896512021 @default.
• W2791689651 countsByYear W27916896512022 @default.
• W2791689651 countsByYear W27916896512023 @default.
• W2791689651 crossrefType "journal-article" @default.
• W2791689651 hasAuthorship W2791689651A5017540902 @default.
• W2791689651 hasAuthorship W2791689651A5056768431 @default.
• W2791689651 hasAuthorship W2791689651A5064526709 @default.
• W2791689651 hasAuthorship W2791689651A5065771148 @default.
• W2791689651 hasAuthorship W2791689651A5081482078 @default.
• W2791689651 hasAuthorship W2791689651A5083267991 @default.
• W2791689651 hasAuthorship W2791689651A5086297428 @default.
• W2791689651 hasBestOaLocation W27916896512 @default.
• W2791689651 hasConcept C124490489 @default.
• W2791689651 hasConcept C125870589 @default.
• W2791689651 hasConcept C126322002 @default.
• W2791689651 hasConcept C131075544 @default.
• W2791689651 hasConcept C134018914 @default.
• W2791689651 hasConcept C142724271 @default.
• W2791689651 hasConcept C160160445 @default.
• W2791689651 hasConcept C170033053 @default.
• W2791689651 hasConcept C181199279 @default.
• W2791689651 hasConcept C204787440 @default.
• W2791689651 hasConcept C27081682 @default.
• W2791689651 hasConcept C2776541429 @default.
• W2791689651 hasConcept C2776886416 @default.
• W2791689651 hasConcept C2779329777 @default.
• W2791689651 hasConcept C55493867 @default.
• W2791689651 hasConcept C673006 @default.
• W2791689651 hasConcept C71924100 @default.
• W2791689651 hasConcept C86803240 @default.
• W2791689651 hasConceptScore W2791689651C124490489 @default.
• W2791689651 hasConceptScore W2791689651C125870589 @default.
• W2791689651 hasConceptScore W2791689651C126322002 @default.
• W2791689651 hasConceptScore W2791689651C131075544 @default.
• W2791689651 hasConceptScore W2791689651C134018914 @default.
• W2791689651 hasConceptScore W2791689651C142724271 @default.

• next